Related Experiment Video
Updated: Jan 13, 2026

Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
Published on: January 20, 2019
Enhancing Safety Evaluations: A Comprehensive Framework for Evidence-Based Safety Assessment Using the Bradford Hill
Anja Loos1, Elian Khazneh2, Jürgen Kübler3
1Merck Healthcare, Darmstadt, Germany. anja-helena.loos@merckgroup.com.
This study introduces a structured framework using the Bradford Hill Criteria for consistent drug safety assessments. It standardizes evidence integration from diverse sources, improving causality reasoning and decision-making throughout drug development.
Area of Science:
- Pharmacovigilance and Drug Safety
- Regulatory Science
- Evidence Synthesis
Background:
- Drug safety assessments integrate diverse data (clinical trials, toxicology, real-world evidence), often facing incompleteness and ambiguity.
- Current methods lack a structured framework for consistent causality reasoning, leading to fragmented evaluations and difficulty in reproducing conclusions.
- Operational challenges include inconsistent interpretation and loss of institutional memory in cross-functional teams.
Purpose of the Study:
- To propose a structured, reusable framework for organizing and critically appraising evidence in drug safety assessments.
- To standardize the interpretation of safety data and facilitate the consistent communication of causality reasoning.
- To address real-life operational challenges in drug development safety evaluations.
Main Methods:
- A structured application of the Bradford Hill Criteria (BHC) is proposed, offering a "plug-and-play" architecture.
- Contemporary interpretation of individual BHC criteria for safety assessments to ensure consistent application.
- Guidance on mapping diverse data types (preclinical, clinical, real-world evidence) into a reproducible causality narrative.
Main Results:
- The framework standardizes the interpretation of heterogeneous safety data sources.
- Enables modular integration of new evidence over time, allowing for iterative updates.
- Facilitates transparent communication and supports informed decision-making in drug development and post-marketing surveillance.
Conclusions:
- The proposed structured Bradford Hill Criteria framework enhances the rigor and consistency of drug safety evaluations.
- It improves the reproducibility of causality assessments and supports robust decision-making across the product lifecycle.
- This approach is valuable for safety planning, regulatory submissions (e.g., IND applications), and ongoing safety surveillance.
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Criteria for Causality: Bradford Hill Criteria - I
Criteria for Causality: Bradford Hill Criteria - II
Hazard Ratio
For example, in a clinical trial...
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...